Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinoma.

about

Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinoma.

Item

http://www.wikidata.org/entity/Q48156557

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Angiosomal radiopathologic ana ...... t of hepatocellular carcinoma.

@en

Angiosomal radiopathologic ana ...... t of hepatocellular carcinoma.

@nl

type

Item

label

Angiosomal radiopathologic ana ...... t of hepatocellular carcinoma.

@en

Angiosomal radiopathologic ana ...... t of hepatocellular carcinoma.

@nl

prefLabel

Angiosomal radiopathologic ana ...... t of hepatocellular carcinoma.

@en

Angiosomal radiopathologic ana ...... t of hepatocellular carcinoma.

@nl

P1476

Angiosomal radiopathologic ana ...... nt of hepatocellular carcinoma

@en

P2093

Amy Collinsworth

http://www.w3.org/2001/XMLSchema#string

Ashwini Esnakula

http://www.w3.org/2001/XMLSchema#string

Chris L Sistrom

http://www.w3.org/2001/XMLSchema#string

Ivan Zendejas

http://www.w3.org/2001/XMLSchema#string

Naziya Samreen

http://www.w3.org/2001/XMLSchema#string

Roniel Cabrera

http://www.w3.org/2001/XMLSchema#string

P2860

The Role of Diffusion-Weighted Imaging (DWI) in Locoregional Therapy Outcome Prediction and Response Assessment for Hepatocellular Carcinoma (HCC): The New Era of Functional Imaging Biomarkers

Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols

Global cancer statistics, 2012

Management of hepatocellular carcinoma: An update

Radioembolization of yttrium-90 microspheres for hepatic malignancy.

Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial.

Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.

Angiographic considerations in patients undergoing liver-directed therapy.

P2888

s00261-017-1354-6

P304

1825-1836

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00261-017-1354-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29052747

http://www.w3.org/2001/XMLSchema#string